data_1tnm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tnm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.404 ' CA ' ' OE1' ' A' ' 81' ' ' GLN . 72.0 mtm180 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.225 0.536 . . . . 0.84 110.266 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.451 ' HA ' HG21 ' A' ' 23' ' ' THR . 36.7 mm 58.97 69.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.37 -0.831 . . . . 0.99 109.938 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 2.1 mp -57.66 -35.79 71.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.777 0.799 . . . . 0.8 109.268 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -163.99 140.27 6.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.92 109.085 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -98.19 159.44 30.7 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.002 -1.061 . . . . 0.86 110.818 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HG2' ' CD1' ' A' ' 85' ' ' PHE . 45.5 Cg_endo -73.37 175.01 11.18 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.846 1.445 . . . . 0.99 110.398 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -152.78 0.42 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.99 110.41 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.75 174.09 13.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.91 110.541 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -174.1 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.705 1.24 . . . . 0.99 111.676 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m -138.44 106.11 5.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.459 -0.941 . . . . 0.97 108.459 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG23 ' CD1' ' A' ' 87' ' ' LEU . 4.7 m -96.08 -172.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.469 -0.892 . . . . 0.95 110.324 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -98.99 -68.63 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.511 -0.743 . . . . 0.98 109.7 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -173.81 102.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.768 . . . . 0.8 109.431 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.47 25.1 75.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.933 -1.667 . . . . 0.97 108.933 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -64.03 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 0.97 110.283 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -151.17 -87.19 0.07 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.495 -0.753 . . . . 0.98 110.587 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' CB ' ' CD2' ' A' ' 87' ' ' LEU . . . 52.18 99.69 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.199 -0.938 . . . . 0.94 111.143 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -134.14 131.77 39.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.824 -0.806 . . . . 0.81 108.824 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.43 ' O ' ' CG2' ' A' ' 56' ' ' THR . 12.1 m-85 -129.87 150.16 51.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.008 . . . . 0.97 110.103 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 31.2 t -159.86 120.55 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.251 -0.906 . . . . 0.95 110.307 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.4 p -117.75 -177.48 3.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.327 -0.858 . . . . 0.99 110.577 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' O ' ' CG2' ' A' ' 23' ' ' THR . 55.2 t0 -137.44 149.3 46.78 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.495 -0.928 . . . . 0.83 108.495 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 22' ' ' ASP . 6.8 p -157.29 133.96 9.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.96 111.481 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 29' ' ' PRO . 7.1 t70 -88.12 166.41 14.43 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.449 -0.9 . . . . 0.93 109.057 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' N ' ' HD3' ' A' ' 29' ' ' PRO . . . -151.94 -149.0 4.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.107 -1.197 . . . . 0.86 110.107 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.6 tm-20 -175.17 71.64 0.28 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.93 110.736 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 28' ' ' VAL . 50.9 Cg_endo -101.74 154.23 4.06 Favored 'Cis proline' 0 C--N 1.319 -1.011 0 C-N-CA 123.415 -1.494 . . . . 0.9 110.161 -1.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 27' ' ' PRO . 45.7 t 52.55 106.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.401 -0.812 . . . . 0.98 111.632 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 51.1 Cg_endo -72.21 -171.49 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.401 1.211 . . . . 0.6 110.688 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.81 152.15 49.61 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.826 -0.805 . . . . 0.98 108.826 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' CG2' ' CG2' ' A' ' 72' ' ' VAL . 4.9 p -123.7 155.72 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.935 -1.103 . . . . 0.91 110.406 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 86.7 m -143.67 77.27 1.55 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.91 110.268 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.511 ' CE3' ' HB ' ' A' ' 72' ' ' VAL . 90.7 m95 -58.89 139.6 56.36 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.939 -1.104 . . . . 0.97 108.446 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.527 ' HA ' HD11 ' A' ' 40' ' ' LEU . 2.1 pt? -176.71 142.05 0.4 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.914 0.864 . . . . 0.97 110.339 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.574 ' CB ' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -177.85 63.22 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.339 -0.986 . . . . 0.98 108.339 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.78 21.56 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.329 -0.989 . . . . 0.98 108.329 -177.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.08 31.37 4.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.5 -1.44 . . . . 0.65 109.5 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.441 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 0.7 OUTLIER 59.21 60.2 2.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -1.153 . . . . 0.93 109.41 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 41' ' ' SER . 34.7 m 37.23 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 112.026 0.38 . . . . 0.97 112.026 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.561 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 5.8 mp 41.7 -91.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.627 -0.508 . . . . 0.86 109.627 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' VAL . 85.7 p 24.49 50.55 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.731 1.011 . . . . 0.91 113.731 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.452 HG21 ' N ' ' A' ' 48' ' ' VAL . 7.6 p 48.24 69.74 0.51 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.093 -1.004 . . . . 0.96 109.306 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.8 m -109.08 -5.68 15.91 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.205 -0.934 . . . . 0.99 111.86 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -179.6 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.848 -1.158 . . . . 0.83 110.478 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -109.09 9.04 26.31 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.474 -0.766 . . . . 0.94 110.689 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.429 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 1.9 m-70 -93.39 -170.62 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.96 -1.088 . . . . 0.98 108.526 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -157.3 45.99 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.913 -1.117 . . . . 0.99 109.077 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 47.0 t -59.46 169.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.451 0.643 . . . . 0.97 110.957 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.454 ' N ' ' CG1' ' A' ' 48' ' ' VAL . 3.0 t -178.85 108.41 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.522 -0.736 . . . . 0.92 109.885 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 17.5 m -88.06 165.06 15.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.86 110.855 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.443 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -135.67 -175.96 4.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.82 110.022 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.11 -72.7 0.06 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.13 0.491 . . . . 0.97 111.452 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -117.97 20.71 13.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.184 -0.948 . . . . 0.97 111.004 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 51' ' ' THR . 10.7 mtmt -155.79 136.8 13.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.082 . . . . 0.99 109.642 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 33.1 t -110.33 174.95 5.62 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.706 -1.198 . . . . 0.93 110.761 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 98.4 m -156.01 130.73 9.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.97 110.137 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 1.3 t80 -112.41 120.21 40.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.273 -0.971 . . . . 0.87 109.182 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.25 142.95 44.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.97 109.904 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 57' ' ' PHE . 2.4 mt -119.07 116.8 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.797 -1.161 . . . . 0.99 110.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 p -134.35 156.1 49.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.115 -0.698 . . . . 0.9 109.115 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p 48.72 27.54 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.98 110.399 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' HG21 ' A' ' 59' ' ' ILE . 4.0 p -64.6 114.42 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.95 110.245 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -82.55 -162.74 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.804 . . . . 0.96 109.943 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 91' ' ' LYS . . . -86.45 48.84 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.988 . . . . 0.94 110.429 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -156.5 45.68 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.96 109.838 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 2.3 m-20 -140.46 -37.58 0.46 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.867 -0.521 . . . . 0.95 110.029 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 66' ' ' ASP . 4.4 pt-20 48.06 173.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.822 0.82 . . . . 0.99 110.752 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 87' ' ' LEU . . . -88.71 -85.95 1.24 Allowed Glycine 0 C--O 1.203 -1.781 0 C-N-CA 120.182 -1.009 . . . . 0.84 113.512 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 68' ' ' GLY . 39.4 m-20 -5.78 79.88 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 121.212 0.53 . . . . 0.95 112.11 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.574 ' HA ' ' CB ' ' A' ' 35' ' ' ARG . 5.4 m-85 -115.17 133.38 56.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.69 -0.631 . . . . 0.9 110.547 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 5.6 m -120.22 179.22 4.36 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.299 -1.361 . . . . 0.89 110.298 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.511 ' HB ' ' CE3' ' A' ' 33' ' ' TRP . 6.9 p -141.77 109.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.592 -0.843 . . . . 0.95 110.667 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 54.0 t -87.79 113.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.077 -1.083 . . . . 0.9 108.077 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' CG1' HG23 ' A' ' 23' ' ' THR . 95.5 t -113.89 123.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.899 -1.125 . . . . 0.94 110.599 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 1.6 mt-10 -109.69 -156.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.94 110.967 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.42 ' OD1' ' CA ' ' A' ' 25' ' ' GLY . 18.9 t30 -171.17 170.27 6.15 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.327 -0.858 . . . . 0.97 109.89 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.8 p -49.41 -23.78 1.66 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.95 110.856 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -156.91 47.35 0.43 Allowed 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.573 -0.704 . . . . 0.91 110.01 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.71 179.48 32.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.786 -1.326 . . . . 0.95 109.786 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -169.11 132.48 1.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.322 -1.105 . . . . 0.96 109.87 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.448 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 4.6 mt-30 -158.35 -171.56 3.52 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.993 -1.067 . . . . 0.98 109.537 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.63 164.34 6.7 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.455 -0.898 . . . . 0.99 110.824 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' CB ' HG11 ' A' ' 72' ' ' VAL . . . -138.17 -179.89 6.05 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.662 -0.866 . . . . 0.97 108.662 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 25.4 pt-20 -164.53 150.32 10.41 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.685 -1.206 . . . . 0.75 111.712 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.493 ' CE1' ' O ' ' A' ' 70' ' ' TYR . 24.2 p90 -165.7 -165.23 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.239 -1.393 . . . . 0.97 107.239 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.459 ' HA ' ' CA ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -153.32 120.37 5.76 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.558 -1.339 . . . . 0.96 111.141 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.575 ' O ' ' HA2' ' A' ' 68' ' ' GLY . 23.2 tp -118.24 86.49 2.54 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.579 -0.701 . . . . 0.94 110.352 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.09 176.6 9.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.329 -1.482 . . . . 0.84 111.943 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.55 ' CD1' ' N ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -145.67 120.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.718 0.77 . . . . 0.98 109.728 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -83.95 72.3 10.44 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.151 -0.968 . . . . 0.97 110.23 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HD2' ' CB ' ' A' ' 64' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 117.999 -1.001 . . . . 0.96 110.351 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.421 ' HA ' ' OE1' ' A' ' 81' ' ' GLN . 72.0 mtm180 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.225 0.536 . . . . 0.72999999999999998 110.266 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 81' ' ' GLN . 36.7 mm 58.97 69.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.37 -0.831 . . . . 0.98999999999999999 109.938 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 23' ' ' THR . 2.1 mp -57.66 -35.79 71.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.777 0.799 . . . . 0.80000000000000004 109.268 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -163.99 140.27 6.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.87 109.085 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -98.19 159.44 30.7 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.002 -1.061 . . . . 0.73999999999999999 110.818 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 85' ' ' PHE . 45.5 Cg_endo -73.37 175.01 11.18 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.846 1.445 . . . . 0.82999999999999996 110.398 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -152.78 0.42 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.98999999999999999 110.41 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.75 174.09 13.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.79000000000000004 110.541 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -174.1 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.705 1.24 . . . . 0.98999999999999999 111.676 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m -138.44 106.11 5.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.459 -0.941 . . . . 0.96999999999999997 108.459 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.834 HG23 HG22 ' A' ' 89' ' ' ILE . 4.7 m -96.08 -172.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.469 -0.892 . . . . 0.94999999999999996 110.324 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -98.99 -68.63 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.511 -0.743 . . . . 0.97999999999999998 109.7 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -173.81 102.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.768 . . . . 0.80000000000000004 109.431 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' H ' HG12 ' A' ' 62' ' ' VAL . . . 68.47 25.1 75.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.933 -1.667 . . . . 0.85999999999999999 108.933 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -64.03 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 0.96999999999999997 110.283 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -151.17 -87.19 0.07 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.495 -0.753 . . . . 0.97999999999999998 110.587 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.004 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . 52.18 99.69 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.199 -0.938 . . . . 0.93999999999999995 111.143 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -134.14 131.77 39.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.824 -0.806 . . . . 0.81000000000000005 108.824 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.785 ' O ' HG23 ' A' ' 56' ' ' THR . 12.1 m-85 -129.87 150.16 51.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.008 . . . . 0.87 110.103 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 31.2 t -159.86 120.55 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.251 -0.906 . . . . 0.94999999999999996 110.307 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' HG ' ' HZ2' ' A' ' 33' ' ' TRP . 27.4 p -117.75 -177.48 3.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.327 -0.858 . . . . 0.98999999999999999 110.577 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 23' ' ' THR . 55.2 t0 -137.44 149.3 46.78 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.495 -0.928 . . . . 0.82999999999999996 108.495 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.81 HG21 HG11 ' A' ' 74' ' ' VAL . 6.8 p -157.29 133.96 9.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.92000000000000004 111.481 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' H ' HD13 ' A' ' 3' ' ' LEU . 7.1 t70 -88.12 166.41 14.43 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.449 -0.9 . . . . 0.93000000000000005 109.057 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.42 ' CA ' ' OD1' ' A' ' 76' ' ' ASN . . . -151.94 -149.0 4.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.107 -1.197 . . . . 0.85999999999999999 110.107 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.6 tm-20 -175.17 71.64 0.28 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.93000000000000005 110.736 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 28' ' ' VAL . 50.9 Cg_endo -101.74 154.23 4.06 Favored 'Cis proline' 0 C--N 1.319 -1.011 0 C-N-CA 123.415 -1.494 . . . . 0.81000000000000005 110.161 -1.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 27' ' ' PRO . 45.7 t 52.55 106.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.401 -0.812 . . . . 0.67000000000000004 111.632 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 51.1 Cg_endo -72.21 -171.49 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.401 1.211 . . . . 0.55000000000000004 110.688 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -129.81 152.15 49.61 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.826 -0.805 . . . . 0.77000000000000002 108.826 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.098 HG23 HG22 ' A' ' 74' ' ' VAL . 4.9 p -123.7 155.72 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.935 -1.103 . . . . 0.91000000000000003 110.406 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.709 ' O ' HD22 ' A' ' 34' ' ' LEU . 86.7 m -143.67 77.27 1.55 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.68999999999999995 110.268 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.827 ' HB3' HD22 ' A' ' 40' ' ' LEU . 90.7 m95 -58.89 139.6 56.36 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.939 -1.104 . . . . 0.96999999999999997 108.446 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 32' ' ' THR . 2.1 pt? -176.71 142.05 0.4 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.914 0.864 . . . . 0.90000000000000002 110.339 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.618 ' CB ' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -177.85 63.22 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.339 -0.986 . . . . 0.92000000000000004 108.339 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.78 21.56 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.329 -0.989 . . . . 0.79000000000000004 108.329 -177.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.08 31.37 4.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.5 -1.44 . . . . 0.65000000000000002 109.5 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' C ' HG22 ' A' ' 39' ' ' VAL . 0.7 OUTLIER 59.21 60.2 2.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -1.153 . . . . 0.93000000000000005 109.41 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.536 HG22 ' C ' ' A' ' 38' ' ' GLN . 34.7 m 37.23 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 112.026 0.38 . . . . 0.95999999999999996 112.026 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.837 HD23 ' CE2' ' A' ' 57' ' ' PHE . 5.8 mp 41.7 -91.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.627 -0.508 . . . . 0.68999999999999995 109.627 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' VAL . 85.7 p 24.49 50.55 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.731 1.011 . . . . 0.91000000000000003 113.731 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.439 HG23 ' HB ' ' A' ' 48' ' ' VAL . 7.6 p 48.24 69.74 0.51 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.093 -1.004 . . . . 0.85999999999999999 109.306 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 25.8 m -109.08 -5.68 15.91 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.205 -0.934 . . . . 0.98999999999999999 111.86 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 43' ' ' SER . . . -179.6 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.848 -1.158 . . . . 0.82999999999999996 110.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -109.09 9.04 26.31 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.474 -0.766 . . . . 0.93999999999999995 110.689 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -93.39 -170.62 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.96 -1.088 . . . . 0.97999999999999998 108.526 179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 4.7 tt0 -157.3 45.99 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.913 -1.117 . . . . 0.87 109.077 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 47.0 t -59.46 169.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.451 0.643 . . . . 0.96999999999999997 110.957 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 49' ' ' THR . 3.0 t -178.85 108.41 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.522 -0.736 . . . . 0.80000000000000004 109.885 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.669 HG23 ' HB2' ' A' ' 55' ' ' SER . 17.5 m -88.06 165.06 15.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.68000000000000005 110.855 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -135.67 -175.96 4.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.58999999999999997 110.022 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' H ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -43.11 -72.7 0.06 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.13 0.491 . . . . 0.96999999999999997 111.452 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -117.97 20.71 13.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.184 -0.948 . . . . 0.96999999999999997 111.004 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 51' ' ' THR . 10.7 mtmt -155.79 136.8 13.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.082 . . . . 0.91000000000000003 109.642 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.669 ' HB2' HG23 ' A' ' 50' ' ' THR . 33.1 t -110.33 174.95 5.62 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.706 -1.198 . . . . 0.68999999999999995 110.761 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 19' ' ' PHE . 98.4 m -156.01 130.73 9.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.96999999999999997 110.137 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.837 ' CE2' HD23 ' A' ' 40' ' ' LEU . 1.3 t80 -112.41 120.21 40.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.273 -0.971 . . . . 0.87 109.182 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -112.25 142.95 44.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.83999999999999997 109.904 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.044 HD12 HD23 ' A' ' 87' ' ' LEU . 2.4 mt -119.07 116.8 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.797 -1.161 . . . . 0.98999999999999999 110.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 p -134.35 156.1 49.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.115 -0.698 . . . . 0.90000000000000002 109.115 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p 48.72 27.54 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.80000000000000004 110.399 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.709 HG11 HG21 ' A' ' 89' ' ' ILE . 4.0 p -64.6 114.42 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.94999999999999996 110.245 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -82.55 -162.74 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.804 . . . . 0.78000000000000003 109.943 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 91' ' ' LYS . . . -86.45 48.84 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.988 . . . . 0.57999999999999996 110.429 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -156.5 45.68 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.95999999999999996 109.838 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 2.3 m-20 -140.46 -37.58 0.46 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.867 -0.521 . . . . 0.94999999999999996 110.029 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 66' ' ' ASP . 4.4 pt-20 48.06 173.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.822 0.82 . . . . 0.79000000000000004 110.752 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 87' ' ' LEU . . . -88.71 -85.95 1.24 Allowed Glycine 0 C--O 1.203 -1.781 0 C-N-CA 120.182 -1.009 . . . . 0.83999999999999997 113.512 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 68' ' ' GLY . 39.4 m-20 -5.78 79.88 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 121.212 0.53 . . . . 0.94999999999999996 112.11 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.628 ' CD1' HD21 ' A' ' 40' ' ' LEU . 5.4 m-85 -115.17 133.38 56.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.69 -0.631 . . . . 0.82999999999999996 110.547 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 5.6 m -120.22 179.22 4.36 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.299 -1.361 . . . . 0.89000000000000001 110.298 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.936 ' CG1' ' HB3' ' A' ' 83' ' ' ALA . 6.9 p -141.77 109.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.592 -0.843 . . . . 0.94999999999999996 110.667 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.702 HG23 HD21 ' A' ' 34' ' ' LEU . 54.0 t -87.79 113.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.077 -1.083 . . . . 0.88 108.077 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.098 HG22 HG23 ' A' ' 31' ' ' VAL . 95.5 t -113.89 123.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.899 -1.125 . . . . 0.93999999999999995 110.599 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 1.6 mt-10 -109.69 -156.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.93999999999999995 110.967 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.42 ' OD1' ' CA ' ' A' ' 25' ' ' GLY . 18.9 t30 -171.17 170.27 6.15 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.327 -0.858 . . . . 0.96999999999999997 109.89 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.8 p -49.41 -23.78 1.66 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.90000000000000002 110.856 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -156.91 47.35 0.43 Allowed 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.573 -0.704 . . . . 0.69999999999999996 110.01 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.71 179.48 32.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.786 -1.326 . . . . 0.94999999999999996 109.786 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -169.11 132.48 1.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.322 -1.105 . . . . 0.85999999999999999 109.87 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 4.6 mt-30 -158.35 -171.56 3.52 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.993 -1.067 . . . . 0.93000000000000005 109.537 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -171.63 164.34 6.7 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.455 -0.898 . . . . 0.98999999999999999 110.824 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.936 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . . . -138.17 -179.89 6.05 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.662 -0.866 . . . . 0.96999999999999997 108.662 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 25.4 pt-20 -164.53 150.32 10.41 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.685 -1.206 . . . . 0.75 111.712 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 69' ' ' ASN . 24.2 p90 -165.7 -165.23 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.239 -1.393 . . . . 0.85999999999999999 107.239 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' CA ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -153.32 120.37 5.76 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.558 -1.339 . . . . 0.95999999999999996 111.141 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.044 HD23 HD12 ' A' ' 59' ' ' ILE . 23.2 tp -118.24 86.49 2.54 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.579 -0.701 . . . . 0.93999999999999995 110.352 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.09 176.6 9.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.329 -1.482 . . . . 0.83999999999999997 111.943 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.834 HG22 HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -145.67 120.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.718 0.77 . . . . 0.92000000000000004 109.728 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -83.95 72.3 10.44 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.151 -0.968 . . . . 0.93999999999999995 110.23 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HD2' ' CB ' ' A' ' 64' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 117.999 -1.001 . . . . 0.95999999999999996 110.351 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.421 ' HA ' ' OE1' ' A' ' 81' ' ' GLN . 72.0 mtm180 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.225 0.536 . . . . 0.73 110.266 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 81' ' ' GLN . 36.7 mm 58.97 69.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.37 -0.831 . . . . 0.99 109.938 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 23' ' ' THR . 2.1 mp -57.66 -35.79 71.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.777 0.799 . . . . 0.8 109.268 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.7 m -163.99 140.27 6.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.085 -0.709 . . . . 0.87 109.085 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -98.19 159.44 30.7 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.002 -1.061 . . . . 0.74 110.818 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 85' ' ' PHE . 45.5 Cg_endo -73.37 175.01 11.18 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.846 1.445 . . . . 0.83 110.398 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -152.78 0.42 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.99 110.41 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.75 174.09 13.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.79 110.541 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.29 -174.1 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.705 1.24 . . . . 0.99 111.676 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m -138.44 106.11 5.61 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.459 -0.941 . . . . 0.97 108.459 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.834 HG23 HG22 ' A' ' 89' ' ' ILE . 4.7 m -96.08 -172.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.469 -0.892 . . . . 0.95 110.324 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -98.99 -68.63 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.511 -0.743 . . . . 0.98 109.7 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -173.81 102.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.768 . . . . 0.8 109.431 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' H ' HG12 ' A' ' 62' ' ' VAL . . . 68.47 25.1 75.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.933 -1.667 . . . . 0.86 108.933 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -64.03 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -1.053 . . . . 0.97 110.283 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.9 m -151.17 -87.19 0.07 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.495 -0.753 . . . . 0.98 110.587 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.004 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . 52.18 99.69 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.199 -0.938 . . . . 0.94 111.143 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -134.14 131.77 39.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.824 -0.806 . . . . 0.81 108.824 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.785 ' O ' HG23 ' A' ' 56' ' ' THR . 12.1 m-85 -129.87 150.16 51.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.008 . . . . 0.87 110.103 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 31.2 t -159.86 120.55 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.251 -0.906 . . . . 0.95 110.307 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' HG ' ' HZ2' ' A' ' 33' ' ' TRP . 27.4 p -117.75 -177.48 3.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.327 -0.858 . . . . 0.99 110.577 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 23' ' ' THR . 55.2 t0 -137.44 149.3 46.78 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.495 -0.928 . . . . 0.83 108.495 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.81 HG21 HG11 ' A' ' 74' ' ' VAL . 6.8 p -157.29 133.96 9.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.92 111.481 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' H ' HD13 ' A' ' 3' ' ' LEU . 7.1 t70 -88.12 166.41 14.43 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.449 -0.9 . . . . 0.93 109.057 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.42 ' CA ' ' OD1' ' A' ' 76' ' ' ASN . . . -151.94 -149.0 4.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.107 -1.197 . . . . 0.86 110.107 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 1.6 tm-20 -175.17 71.64 0.28 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.93 110.736 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 28' ' ' VAL . 50.9 Cg_endo -101.74 154.23 4.06 Favored 'Cis proline' 0 C--N 1.319 -1.011 0 C-N-CA 123.415 -1.494 . . . . 0.81 110.161 -1.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 27' ' ' PRO . 45.7 t 52.55 106.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.401 -0.812 . . . . 0.67 111.632 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 51.1 Cg_endo -72.21 -171.49 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.401 1.211 . . . . 0.55 110.688 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.568 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -129.81 152.15 49.61 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.826 -0.805 . . . . 0.77 108.826 179.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.098 HG23 HG22 ' A' ' 74' ' ' VAL . 4.9 p -123.7 155.72 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.935 -1.103 . . . . 0.91 110.406 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.709 ' O ' HD22 ' A' ' 34' ' ' LEU . 86.7 m -143.67 77.27 1.55 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.69 110.268 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.827 ' HB3' HD22 ' A' ' 40' ' ' LEU . 90.7 m95 -58.89 139.6 56.36 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.939 -1.104 . . . . 0.97 108.446 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 32' ' ' THR . 2.1 pt? -176.71 142.05 0.4 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.914 0.864 . . . . 0.9 110.339 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.618 ' CB ' ' HA ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -177.85 63.22 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.339 -0.986 . . . . 0.92 108.339 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.78 21.56 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.329 -0.989 . . . . 0.79 108.329 -177.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.08 31.37 4.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.5 -1.44 . . . . 0.65 109.5 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' C ' HG22 ' A' ' 39' ' ' VAL . 0.7 OUTLIER 59.21 60.2 2.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.24 -1.153 . . . . 0.93 109.41 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.536 HG22 ' C ' ' A' ' 38' ' ' GLN . 34.7 m 37.23 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 112.026 0.38 . . . . 0.96 112.026 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.837 HD23 ' CE2' ' A' ' 57' ' ' PHE . 5.8 mp 41.7 -91.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.627 -0.508 . . . . 0.69 109.627 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 39' ' ' VAL . 85.7 p 24.49 50.55 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 113.731 1.011 . . . . 0.91 113.731 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.439 HG23 ' HB ' ' A' ' 48' ' ' VAL . 7.6 p 48.24 69.74 0.51 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.093 -1.004 . . . . 0.86 109.306 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 25.8 m -109.08 -5.68 15.91 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.205 -0.934 . . . . 0.99 111.86 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 43' ' ' SER . . . -179.6 -79.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.848 -1.158 . . . . 0.83 110.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -109.09 9.04 26.31 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.474 -0.766 . . . . 0.94 110.689 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 1.9 m-70 -93.39 -170.62 2.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.96 -1.088 . . . . 0.98 108.526 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 4.7 tt0 -157.3 45.99 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.913 -1.117 . . . . 0.87 109.077 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 47.0 t -59.46 169.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.451 0.643 . . . . 0.97 110.957 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 49' ' ' THR . 3.0 t -178.85 108.41 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.522 -0.736 . . . . 0.8 109.885 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.669 HG23 ' HB2' ' A' ' 55' ' ' SER . 17.5 m -88.06 165.06 15.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.084 -1.01 . . . . 0.68 110.855 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -135.67 -175.96 4.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.59 110.022 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' H ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -43.11 -72.7 0.06 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.13 0.491 . . . . 0.97 111.452 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' O ' ' CG ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -117.97 20.71 13.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.184 -0.948 . . . . 0.97 111.004 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 51' ' ' THR . 10.7 mtmt -155.79 136.8 13.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.082 . . . . 0.91 109.642 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.669 ' HB2' HG23 ' A' ' 50' ' ' THR . 33.1 t -110.33 174.95 5.62 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.706 -1.198 . . . . 0.69 110.761 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 19' ' ' PHE . 98.4 m -156.01 130.73 9.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.97 110.137 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.837 ' CE2' HD23 ' A' ' 40' ' ' LEU . 1.3 t80 -112.41 120.21 40.89 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.273 -0.971 . . . . 0.87 109.182 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -112.25 142.95 44.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.84 109.904 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.044 HD12 HD23 ' A' ' 87' ' ' LEU . 2.4 mt -119.07 116.8 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.797 -1.161 . . . . 0.99 110.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 p -134.35 156.1 49.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.115 -0.698 . . . . 0.9 109.115 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p 48.72 27.54 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.8 110.399 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.709 HG11 HG21 ' A' ' 89' ' ' ILE . 4.0 p -64.6 114.42 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.95 110.245 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -82.55 -162.74 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.804 . . . . 0.78 109.943 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 91' ' ' LYS . . . -86.45 48.84 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.118 -0.988 . . . . 0.58 110.429 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.3 p -156.5 45.68 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.96 109.838 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 2.3 m-20 -140.46 -37.58 0.46 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.867 -0.521 . . . . 0.95 110.029 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 66' ' ' ASP . 4.4 pt-20 48.06 173.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.822 0.82 . . . . 0.79 110.752 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 87' ' ' LEU . . . -88.71 -85.95 1.24 Allowed Glycine 0 C--O 1.203 -1.781 0 C-N-CA 120.182 -1.009 . . . . 0.84 113.512 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 68' ' ' GLY . 39.4 m-20 -5.78 79.88 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 121.212 0.53 . . . . 0.95 112.11 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.628 ' CD1' HD21 ' A' ' 40' ' ' LEU . 5.4 m-85 -115.17 133.38 56.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.69 -0.631 . . . . 0.83 110.547 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 5.6 m -120.22 179.22 4.36 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.299 -1.361 . . . . 0.89 110.298 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.936 ' CG1' ' HB3' ' A' ' 83' ' ' ALA . 6.9 p -141.77 109.42 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 119.592 -0.843 . . . . 0.95 110.667 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.702 HG23 HD21 ' A' ' 34' ' ' LEU . 54.0 t -87.79 113.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.077 -1.083 . . . . 0.88 108.077 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.098 HG22 HG23 ' A' ' 31' ' ' VAL . 95.5 t -113.89 123.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.899 -1.125 . . . . 0.94 110.599 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 1.6 mt-10 -109.69 -156.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.94 110.967 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.42 ' OD1' ' CA ' ' A' ' 25' ' ' GLY . 18.9 t30 -171.17 170.27 6.15 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.327 -0.858 . . . . 0.97 109.89 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 81.8 p -49.41 -23.78 1.66 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.9 110.856 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -156.91 47.35 0.43 Allowed 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.573 -0.704 . . . . 0.7 110.01 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.71 179.48 32.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.786 -1.326 . . . . 0.95 109.786 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -169.11 132.48 1.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.322 -1.105 . . . . 0.86 109.87 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 4.6 mt-30 -158.35 -171.56 3.52 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.993 -1.067 . . . . 0.93 109.537 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -171.63 164.34 6.7 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.455 -0.898 . . . . 0.99 110.824 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.936 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . . . -138.17 -179.89 6.05 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.662 -0.866 . . . . 0.97 108.662 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 25.4 pt-20 -164.53 150.32 10.41 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.685 -1.206 . . . . 0.75 111.712 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 69' ' ' ASN . 24.2 p90 -165.7 -165.23 0.8 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.239 -1.393 . . . . 0.86 107.239 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' CA ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -153.32 120.37 5.76 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.558 -1.339 . . . . 0.96 111.141 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.044 HD23 HD12 ' A' ' 59' ' ' ILE . 23.2 tp -118.24 86.49 2.54 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.579 -0.701 . . . . 0.94 110.352 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.09 176.6 9.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.329 -1.482 . . . . 0.84 111.943 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.834 HG22 HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -145.67 120.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.718 0.77 . . . . 0.92 109.728 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -83.95 72.3 10.44 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.151 -0.968 . . . . 0.94 110.23 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HD2' ' CB ' ' A' ' 64' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 117.999 -1.001 . . . . 0.96 110.351 -179.834 . . . . . . . . 2 2 . 1 stop_ save_